[EGRX] Eagle Pharmaceuticals, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 730.08 M

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 80.93 Change: 5.35 (7.08%)
Ext. hours: Change: 0 (0%)

chart EGRX

Refresh chart

Strongest Trends Summary For EGRX

EGRX is in the medium-term down -37% below S&P in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company markets EP-1101 (argatroban) to treat heparin-induced thrombocytopenia. It develops EP-3101, a bendamustine ready to dilute (RTD) liquid and EP-3102, a bendamustine short infusion time RTD liquid for the treatment of chronic lymphocytic leukemia and non-Hodgkin's lymphoma; Ryanodex, a dantrolene to treat malignant hyperthermia; and EP-4104, a dantrolene that has completed a Phase I clinical study for the treatment of exertional heat stroke. The company also develops EP-5101 (pemetrexed) as RTD liquid, which is in pre-clinical formulation and toxicology studies to treat lung cancer; EP-6101, a bivalirudin RTU liquid formulation for the treatment of percutaneous transluminal angioplasty; and EP-2101 (topotecan) to treat ovarian, cervical, and small-cell lung cancers. Eagle Pharmaceuticals, Inc. was found

Fundamental Ratios
Shares Outstanding15.64 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 526.88% Sales Growth - Q/Q548.38% P/E
P/E To EPS Growth P/S14.45 P/BV7.1 Price/Cash Per Share
Price/Free Cash Flow-52.57 ROA1.66% ROE2.09% ROI
Current Ratio4.8 Quick Ratio4.72 Long Term Debt/Equity Debt Ratio0.26
Gross Margin71.95% Operating Margin2.84% Net Profit Margin4.26% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities55.29 M Cash From Investing Activities3.95 M Cash From Operating Activities17.96 M Gross Profit30.36 M
Net Profit19.7 M Operating Profit20.09 M Total Assets129.93 M Total Current Assets129.79 M
Total Current Liabilities27.05 M Total Debt Total Liabilities27.05 M Total Revenue36.31 M
Technical Data
High 52 week83.86 Low 52 week36.72 Last close47.79 Last change3.37%
RSI69.97 Average true range1.75 Beta1.26 Volume253.51 K
Simple moving average 20 days14.39% Simple moving average 50 days15.16% Simple moving average 200 days-21.32%
Performance Data
Performance Week14.06% Performance Month14.41% Performance Quart0.46% Performance Half-41.43%
Performance Year-26.5% Performance Year-to-date18.62% Volatility daily2.62% Volatility weekly5.86%
Volatility monthly12% Volatility yearly41.57% Relative Volume311.49% Average Volume212.34 K
New High New Low

News

2019-06-15 08:05:07 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-06-13 08:02:18 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-06-11 08:02:57 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-06-10 08:05:21 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-06-06 08:05:01 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-06-04 08:05:13 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-05-31 15:07:47 | Here's Why I Think Eagle Pharmaceuticals NASDAQ:EGRX Might Deserve Your Attention Today

2019-05-28 16:30:00 | Eagle Pharmaceuticals, Inc. to Present at Jefferies 2019 Global Healthcare Conference

2019-05-15 16:30:00 | Eagle Pharmaceuticals, Inc. to Present at 2019 RBC Capital Markets Global Healthcare Conference

2019-05-09 20:43:25 | Hedge Funds Have Never Been More Bullish On Eagle Pharmaceuticals Inc EGRX

2019-05-08 06:00:00 | Can Eagle Pharma Fly through its Oncology Trials

2019-05-07 17:50:27 | Edited Transcript of EGRX earnings conference call or presentation 7-May-19 12:30pm GMT

2019-05-07 12:23:21 | Eagle Pharmaceuticals Inc EGRX Q1 2019 Earnings Call Transcript

2019-05-07 08:05:12 | Eagle Pharmaceuticals EGRX Beats Q1 Earnings and Revenue Estimates

2019-05-07 08:04:35 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-05-07 07:04:52 | Did You Miss Eagle Pharmaceuticals's NASDAQ:EGRX Whopping 457% Share Price Gain?

2019-05-07 06:58:29 | Eagle Pharmaceuticals: 1Q Earnings Snapshot

2019-05-07 06:50:00 | Eagle Pharmaceuticals, Inc. Reports First Quarter 2019 Results

2019-05-07 06:45:00 | Eagle Pharmaceuticals Announces Positive Results of a Study Conducted in Partnership with the U.S. Military to Evaluate Neuroprotective Effects of RYANODEX for the Treatment of Nerve Agent Exposure

2019-04-30 10:32:02 | Eagle Pharmaceuticals EGRX Earnings Expected to Grow: What to Know Ahead of Next Week's Release

2019-04-30 08:04:49 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-04-29 06:50:00 | Eagle Pharmaceuticals to Discuss First Quarter 2019 Financial Results on May 7, 2019

2019-04-22 09:48:01 | New Strong Sell Stocks for April 22nd

2019-04-22 06:50:00 | CMS Establishes Unique J-Code for BELRAPZO™ Bendamustine 500mL Hydrochloride Injection

2019-04-15 06:50:00 | Eagle Pharmaceuticals, Inc. Expands Licensing Agreement for BENDEKA™ with Teva Pharmaceuticals International GmbH

2019-04-09 10:48:39 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-04-03 14:09:35 | Don't Sell Eagle Pharmaceuticals, Inc. NASDAQ:EGRX Before You Read This

2019-04-02 11:52:41 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-03-28 07:35:00 | Consolidated Research: 2019 Summary Expectations for Penn National Gaming, Nomad Foods, Americold Realty Trust, Cboe Global Markets, Eagle Pharmaceuticals, and National Commerce — Fundamental Analysis, Key Performance Indications

2019-03-26 08:22:07 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-03-12 10:26:50 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-03-01 06:42:51 | Edited Transcript of EGRX earnings conference call or presentation 28-Feb-19 1:30pm GMT

2019-02-28 14:44:04 | Eagle Pharmaceuticals Inc EGRX Q4 2018 Earnings Conference Call Transcript

2019-02-28 06:50:00 | Eagle Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2018 Results

2019-02-28 06:30:00 | Eagle Pharmaceuticals, Inc. to Host Earnings Call

2019-02-21 11:06:34 | Is Eagle Pharmaceuticals, Inc.’s NASDAQ:EGRX ROE Of 15% Impressive?

2019-02-21 10:31:03 | Analysts Estimate Eagle Pharmaceuticals EGRX to Report a Decline in Earnings: What to Look Out for

2019-02-19 16:30:00 | Eagle Pharmaceuticals to Discuss Fourth Quarter and Full Year 2018 Financial Results on February 28, 2019

2019-02-18 10:30:03 | Earnings Preview: Eagle Pharmaceuticals EGRX Q4 Earnings Expected to Decline

2019-02-14 09:10:02 | Should Value Investors Buy Eagle Pharmaceuticals EGRX Stock?

2019-02-08 08:04:04 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-01-15 08:03:38 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-01-09 08:05:36 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-01-08 08:05:14 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2019-01-04 06:51:45 | Does Eagle Pharmaceuticals, Inc.’s NASDAQ:EGRX CEO Pay Matter?

2019-01-02 07:00:00 | Eagle Pharmaceuticals, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference

2018-12-25 08:04:32 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2018-12-20 08:06:10 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2018-12-18 08:06:42 | See what the IHS Markit Score report has to say about Eagle Pharmaceuticals Inc.

2018-12-16 22:49:15 | Hedge Funds Are Selling Eagle Pharmaceuticals Inc EGRX